| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/20/2001 | US20010053533 Detecting infectious protein in solution; prepare solution composed from body fluid or fluidized organ expose to chromatographic column, detect infectious protein |
| 12/20/2001 | US20010053531 Device for determining a substance contained in a body fluid |
| 12/20/2001 | US20010053529 Apparatus for immunological detection of preferential antigen, antibody or hapten |
| 12/20/2001 | US20010053528 Immobilization on solid support |
| 12/20/2001 | US20010053527 Arrays with mask layers and methods of manufacturing same |
| 12/20/2001 | US20010053523 Method for identification of biologically active peptides and nucleic acids |
| 12/20/2001 | US20010053521 Apparatus for detection of spectroscopic signals |
| 12/20/2001 | US20010053520 Methods of making and using microarrays of biological materials |
| 12/20/2001 | US20010053518 Simple and accurate detetion of ribonucleic acids in a sample; generate mixture, detect signal from sample |
| 12/20/2001 | US20010053497 Arrays with mask layers and methods of manufacturing same |
| 12/20/2001 | US20010053371 Molecule having an IL13-moiety and a cytotoxic moiety; especially for reducing growth of glioblastoma multiforme cells. |
| 12/20/2001 | US20010053351 Inhibition of GSK-3 beta |
| 12/20/2001 | US20010053348 Method for testing sunscreens |
| 12/20/2001 | US20010053334 Microarray fabrication techniques and apparatus |
| 12/20/2001 | US20010052770 Method and apparatus for making measurements of accumulations of magnetic particles |
| 12/20/2001 | US20010052769 Method and apparatus for making measurements of accumlations of magnetic particles |
| 12/20/2001 | US20010052492 Filter bag |
| 12/20/2001 | US20010052470 Electrochemical cell |
| 12/20/2001 | US20010052269 Methods and apparatus for determining the location of a shaft within a vessel |
| 12/20/2001 | US20010052256 Gas sensor arrangement |
| 12/20/2001 | DE10030193A1 Test kit for determining total protein and globulins, useful for diagnosing kidney disease, comprises copper sulfate as additional precipitant and polysaccharide |
| 12/20/2001 | DE10029515A1 Hardness test device for vehicle seat, has cylindrical pressing-in pin arranged inside housing such that one end projects out of base plate that is loosely fastened to housing |
| 12/20/2001 | DE10028915A1 Cylindrical object diagnosing method e.g. for drilling samples, involves fixing object to configuration ring that has guide sleeves for placing pulse transmitter and pulse receiver, at equal intervals |
| 12/20/2001 | DE10028837A1 Detecting infection by influenza A or B virus, comprises rapid analysis of a saliva sample, with detection of nucleic acid or nucleoprotein |
| 12/20/2001 | DE10028391A1 Arrangement for burning mineral oil samples and analyzing trace materials, e.g. sulfur, nitrogen and halogens comprises combustion tube containing filler made of tungsten oxide in granulate form |
| 12/20/2001 | DE10027607A1 Applying micro- or nanoparticles of magnetically interacting material, loaded with e.g. nucleic acids to a magnetic carrier for analysis, comprises applying an external magnetic field to accelerate particles into recesses |
| 12/20/2001 | DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
| 12/20/2001 | CA2804117A1 Method for modifying plant morphology, biochemistry and physiology |
| 12/20/2001 | CA2415319A1 Recombinant phycobiliprotein and phycobiliprotein linker fusion proteins and uses therefore |
| 12/20/2001 | CA2413634A1 Method and apparatus for combined magnetophoretic and dielectrophoretic manipulation of analyte mixtures |
| 12/20/2001 | CA2413194A1 Systems and methods for cell subpopulation analysis |
| 12/20/2001 | CA2413160A1 Human tumor necrosis factor delta and epsilon |
| 12/20/2001 | CA2413022A1 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 12/20/2001 | CA2413020A1 Detection of nucleic acids by type-specific hybrid capture method |
| 12/20/2001 | CA2413013A1 Novel motor proteins and methods for their use |
| 12/20/2001 | CA2413003A1 Immunoassays for anti-hcv antibodies |
| 12/20/2001 | CA2412998A1 Methods of dissociating nongenotropic from genotropic activity of steroid receptors |
| 12/20/2001 | CA2412966A1 Compositions containing a urea derivative dye for detecting an analyte |
| 12/20/2001 | CA2412769A1 Toxicity typing using mesenchymal stem cells |
| 12/20/2001 | CA2412720A1 Method for identifying compounds with anti-herpes activity |
| 12/20/2001 | CA2412665A1 Scramblase 2 |
| 12/20/2001 | CA2412664A1 Regulatable, catalytically active nucleic acids |
| 12/20/2001 | CA2412663A1 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 12/20/2001 | CA2412579A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 12/20/2001 | CA2412521A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
| 12/20/2001 | CA2412317A1 A method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality |
| 12/20/2001 | CA2412257A1 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2412217A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
| 12/20/2001 | CA2411956A1 Quasi-static viscometer |
| 12/20/2001 | CA2411190A1 Molecular docking methods for assessing complementarity of combinatorial libraries to biotargets |
| 12/20/2001 | CA2411179A1 Method for increasing luminescence assay sensitivity |
| 12/20/2001 | CA2411036A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues |
| 12/20/2001 | CA2410659A1 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | CA2410610A1 Human kinases |
| 12/20/2001 | CA2410604A1 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/20/2001 | CA2410229A1 Vaccine for congenital tremors in pigs |
| 12/20/2001 | CA2409400A1 Dielectrically-engineered microparticles |
| 12/20/2001 | CA2409315A1 Protein phosphatases |
| 12/20/2001 | CA2373139A1 Immunoassay and immunoassay apparatus |
| 12/20/2001 | CA2351275A1 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 12/19/2001 | EP1164376A1 Method for quantitating cholesterol |
| 12/19/2001 | EP1164375A2 Assay for anti transglutaminase antibodies |
| 12/19/2001 | EP1164374A1 Method for identifying apoptosis-modified proteins |
| 12/19/2001 | EP1164372A2 Microchip-based carbon dioxide gas sensor |
| 12/19/2001 | EP1164202A1 Mismatch-recognizing molecules |
| 12/19/2001 | EP1164200A2 Method and device for drug-drug interaction testing sample preparation |
| 12/19/2001 | EP1164191A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor proteins, bg3 |
| 12/19/2001 | EP1164186A2 Method for investigating membrane enclosed biocompartments |
| 12/19/2001 | EP1164142A1 Novel proteins and uses thereof |
| 12/19/2001 | EP1164136A1 Long wavelength absorbing bacteriochlorin alkyl ether analogs |
| 12/19/2001 | EP1163639A1 Protein modeling tools |
| 12/19/2001 | EP1163528A2 Prediction of diabetes impaired wound healing |
| 12/19/2001 | EP1163527A1 Diagnosis of lysosomal storage disorders using saposins and other markers |
| 12/19/2001 | EP1163526A2 High throughput assay based on the use of a polypeptide binding pair |
| 12/19/2001 | EP1163525A1 Cause, in vitro determination and eradication of cancer |
| 12/19/2001 | EP1163524A2 Methods of screening for colorectal cancer modulators |
| 12/19/2001 | EP1163523A1 Method for detecting predisposition to a venous thromboembolic disease |
| 12/19/2001 | EP1163522A1 Method for detecting superantigen activity in a biological sample |
| 12/19/2001 | EP1163521A2 Assays, methods and means |
| 12/19/2001 | EP1163520A1 Porous coatings bearing ligand arrays |
| 12/19/2001 | EP1163519A1 Protein isolation and analysis |
| 12/19/2001 | EP1163518A2 Elisa kit for the determination of metabolic phenotypes |
| 12/19/2001 | EP1163517A2 Method of screening candidate compounds for susceptibility to biliary excretion |
| 12/19/2001 | EP1163516A1 Effect of brefeldin a on antigen-presenting cells |
| 12/19/2001 | EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 12/19/2001 | EP1163514A1 AN $i(IN VIVO) AND $i(IN VITRO) MODEL FOR CUTANEOUS PHOTOAGING AND OXIDATIVE DAMAGE |
| 12/19/2001 | EP1163513A1 Analyzing strip having a fluid cell and a method of analyzing a sample |
| 12/19/2001 | EP1163502A1 System and method for identifying and analyzing rare cell types in a mixed population of cells |
| 12/19/2001 | EP1163367A2 Analysis of differential gene expression |
| 12/19/2001 | EP1163364A1 Screening method involving mgdg synthase |
| 12/19/2001 | EP1163363A2 Compositions and methods for monitoring the modification of natural binding partners |
| 12/19/2001 | EP1163361A2 A diagnostic test |
| 12/19/2001 | EP1163360A2 Composition and device for detecting leukocytes in urine |
| 12/19/2001 | EP1163345A1 Fungal beta-tubulin genes |
| 12/19/2001 | EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/19/2001 | EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
| 12/19/2001 | EP1163332A1 48 human secreted proteins |
| 12/19/2001 | EP1163331A1 50 human secreted proteins |